340B Drug Pricing Program
A federal program requiring drug manufacturers to provide outpatient drugs at significantly reduced prices (25-50% off) to eligible healthcare organizations serving low-income patients. Hospitals buy at discounted prices but are reimbursed at full rates, creating a significant margin.